STATE OF WISCONSIN INVESTMENT BOARD - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$418,132
-47.7%
237,575
-6.7%
0.00%
-66.7%
Q4 2022$799,815
+29.6%
254,718
+102.3%
0.00%
+50.0%
Q3 2022$617,000
+12.4%
125,940
-5.0%
0.00%
+100.0%
Q2 2022$549,000
-39.1%
132,568
-14.5%
0.00%
-50.0%
Q1 2022$901,000
-22.5%
155,0000.0%0.00%0.0%
Q4 2021$1,162,000
-16.8%
155,0000.0%0.00%
-33.3%
Q3 2021$1,397,000
-24.7%
155,0000.0%0.00%
-25.0%
Q2 2021$1,855,000
-4.5%
155,0000.0%0.00%0.0%
Q1 2021$1,942,000
-24.8%
155,000
-6.4%
0.00%
-33.3%
Q4 2020$2,584,000
+46.8%
165,600
-11.1%
0.01%
+50.0%
Q3 2020$1,760,000
+10.2%
186,200
+4.5%
0.00%0.0%
Q2 2020$1,597,000
+41.5%
178,200
+0.5%
0.00%0.0%
Q1 2020$1,129,000
-21.5%
177,300
+3.2%
0.00%0.0%
Q4 2019$1,438,000
-7.5%
171,8000.0%0.00%0.0%
Q3 2019$1,555,000
-2.0%
171,800
+16.6%
0.00%0.0%
Q2 2019$1,586,000
-15.9%
147,300
-25.5%
0.00%
-20.0%
Q1 2019$1,885,000
+56.7%
197,600
+88.5%
0.01%
+25.0%
Q4 2018$1,203,000
-31.3%
104,800
+1.5%
0.00%
-20.0%
Q3 2018$1,751,000
+19.4%
103,3000.0%0.01%
+25.0%
Q2 2018$1,467,000
-7.2%
103,300
+24.2%
0.00%
-20.0%
Q1 2018$1,581,000
+15.9%
83,2000.0%0.01%
+25.0%
Q4 2017$1,364,000
+71.6%
83,200
+57.0%
0.00%
+100.0%
Q3 2017$795,000
+70.6%
53,0000.0%0.00%0.0%
Q2 2017$466,00053,0000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lombard Odier Asset Management (Switzerland) SA 1,539,994$11,550,0000.74%
Golden State Equity Partners 143,768$1,078,0000.54%
Rhenman & Partners Asset Management AB 765,000$5,975,0000.40%
WASATCH ADVISORS LP 10,960,982$82,207,0000.34%
KLK CAPITAL MANAGEMENT LLC 44,323$332,0000.32%
EMC Capital Management 61,394$460,0000.25%
Rokos Capital Management LLP 539,860$4,108,0000.25%
Long Focus Capital Management, LLC 245,000$1,838,0000.24%
Vanguard Capital Wealth Advisors 33,380$250,0000.18%
Fort Sheridan Advisors LLC 74,898$562,0000.16%
View complete list of SANGAMO THERAPEUTICS INC shareholders